Immunoclin (Immunoclin) Total Payout Ratio : 0.00 (As of May. 26, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Immunoclin's current Total Payout Ratio is 0.00.

Immunoclin Total Payout Ratio Historical Data

The historical data trend for Immunoclin's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Total Payout Ratio Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Total Payout Ratio

0.15

0.19

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Total Payout Ratio	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Immunoclin's Total Payout Ratio

For the Biotechnology subindustry, Immunoclin's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunoclin's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunoclin's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Immunoclin's Total Payout Ratio falls into.

Immunoclin Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Immunoclin's Total Payout Ratio for the fiscal year that ended in Jan. 2014 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	-12.98
	=	0.00

Immunoclin's Total Payout Ratio for the quarter that ended in Oct. 2014 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	-6.117
	=	0.00

Immunoclin Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Immunoclin's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines